| http://www.w3.org/ns/prov#value | - In some embodiments, a method disclosed herein comprises first administering DNA damaging agents including radiation and chemotherapy, followed by administration of an NQO1 bioactivatable drug (such as ??-lap), to take advantage of the tumor-selective amplifying effect of ??-lap on DNA damage, for optimal clinical benefit.In some embodiments, tumor exposure to an NQO1 bioactivatable drug (such as
|
